Tower Research Capital LLC (Trc) Pep Gen Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.53 Billion
- Q2 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Pep Gen Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 9,570 shares of PEPG stock, worth $11,675. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,570
Previous 6,159
55.38%
Holding current value
$11,675
Previous $8,000
25.0%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding PEPG
# of Institutions
52Shares Held
23.6MCall Options Held
0Put Options Held
0-
Ra Capital Management, L.P. Boston, MA10.7MShares$13 Million0.26% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct2.76MShares$3.37 Million0.01% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.51MShares$1.84 Million0.0% of portfolio
-
Viking Global Investors LP1.48MShares$1.81 Million0.01% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA1.35MShares$1.65 Million0.0% of portfolio
About PepGen Inc.
- Ticker PEPG
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 23,631,900
- Market Cap $28.8M
- Description
- PepGen Inc., a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases. The company's lead product candidate is PGN-EDO51, an EDO peptide in Phase I clinical trials to treat individuals with Duchenne muscular dystrophy (DMD). It is a...